{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:14:50Z","timestamp":1777630490884,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jocd.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T22:35:40Z","timestamp":1620772540000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Effect of Pregabalin on Bone Metabolism"],"prefix":"10.1016","volume":"25","author":[{"given":"Burcak","family":"Akin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayram","family":"Kelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"Kozanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2021.05.001_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1590\/S0034-89102006000200016","article-title":"Health-related quality of life in spanish women with osteoporosis","volume":"40","author":"Aranha","year":"2006","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.jocd.2021.05.001_bib0002","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0025-6196(11)62214-3","article-title":"Secondary causes of osteoporosis","volume":"77","author":"Fitzpatrick","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.jocd.2021.05.001_bib0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/0004-282x20180068","article-title":"Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients","volume":"76","author":"El-Haggar","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.jocd.2021.05.001_bib0004","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density\u2013evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jocd.2021.05.001_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","article-title":"A review of the effect of anticonvulsant medications on bone mineral density and fracture risk","volume":"8","author":"Lee","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"issue":"6","key":"10.1016\/j.jocd.2021.05.001_bib0006","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","article-title":"Bone mineral density in adult patients treated with various antiepileptic drugs","volume":"21","author":"Beniczky","year":"2012","journal-title":"Seizure"},{"issue":"1-2","key":"10.1016\/j.jocd.2021.05.001_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2013.05.005","article-title":"Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors","volume":"15","author":"Beerhorst","year":"2013","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jocd.2021.05.001_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yebeh.2011.05.001","article-title":"Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs","volume":"21","author":"Pack","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocd.2021.05.001_bib0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000324919.86696.a9","article-title":"Antiepileptic drug use and rates of hip bone loss in older men: A prospective study","volume":"71","author":"Ensrud","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocd.2021.05.001_bib0011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archneurol.2010.341","article-title":"Association of antiepileptic drugs with nontraumatic fractures: A population-based analysis","volume":"68","author":"Jett\u00e9","year":"2011","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.jocd.2021.05.001_bib0012","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.b17-00482","article-title":"Effects of the antiepileptic drugs phenytoin, gabapentin, and levetiracetam on bone strength, bone mass, and bone turnover in rats","volume":"40","author":"Kanda","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jocd.2021.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP12119.OR","article-title":"The association of newer anticonvulsant medications and bone mineral density","volume":"14","author":"Lee","year":"2012","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jocd.2021.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.pharep.2019.08.004","article-title":"The effect of gabapentin and pregabalin on bone turnover and bone strength: A prospective study in Wistar rats","volume":"71","author":"Simko","year":"2019","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.jocd.2021.05.001_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.6065\/apem.2020.25.1.15","article-title":"Bone health in pediatric patients with neurological disorders","volume":"25","author":"Ko","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jocd.2021.05.001_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/164_2019_340","article-title":"Drugs causing bone loss","volume":"262","author":"Vestergaard","year":"2019","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0018","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/epi.12049","article-title":"The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin","volume":"54","author":"Phabphal","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000229309","article-title":"Bone disease induced by phenytoin therapy: clinical and experimental study","volume":"62","author":"Moro-Alvarez","year":"2009","journal-title":"Eur Neurol"},{"issue":"18","key":"10.1016\/j.jocd.2021.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","article-title":"Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy","volume":"70","author":"Pack","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0021","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5455\/medarh.2018.72.262-266","article-title":"Effect of long-term carbamazepine therapy on bone health","volume":"72","author":"Suljic","year":"2018","journal-title":"Med Arch"},{"issue":"6","key":"10.1016\/j.jocd.2021.05.001_bib0022","first-page":"317","article-title":"Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy","volume":"48","author":"Chou","year":"2007","journal-title":"Acta Paediatr Taiwan"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2007.11.020","article-title":"Bone health in people with epilepsy: is it impaired and what are the risk factors?","volume":"17","author":"Pack","year":"2008","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.jocd.2021.05.001_bib0024","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00023210-200115080-00006","article-title":"Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications","volume":"15","author":"Pack","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocd.2021.05.001_bib0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euroneuro.2006.04.005","article-title":"Pregabalin: from molecule to medicine","volume":"16","author":"Kavoussi","year":"2006","journal-title":"Euro Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0026","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2005.12.008","article-title":"Pregabalin in neuropathic pain: a more \"pharmaceutically elegant\" gabapentin?","volume":"3","author":"Guay","year":"2005","journal-title":"Am Geriatr Pharmacother"},{"issue":"8","key":"10.1016\/j.jocd.2021.05.001_bib0027","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1358\/dof.1999.024.08.545995","article-title":"Pregabalin","volume":"24","author":"Martin","year":"1999","journal-title":"Drugs of the Future."},{"key":"10.1016\/j.jocd.2021.05.001_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0013-9580.2004.455004.x","article-title":"Pregabalin as adjunctive therapy for partial seizures","volume":"45","author":"Brodie","year":"2004","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","article-title":"Bone mineral density with lamotrigine monotherapy for epilepsy","volume":"37","author":"Sheth","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0031","first-page":"96","article-title":"Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy (Abstract)","volume":"12","author":"Zhang","year":"2010","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.jocd.2021.05.001_bib0032","first-page":"873","article-title":"Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy","volume":"18","author":"Schmitt","year":"1984","journal-title":"J Fam Pract"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0033","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1475-097X.1983.tb00718.x","article-title":"Relationship between local and total body bone mineral in epileptic patients and normal subjects","volume":"3","author":"Tjellesen","year":"1983","journal-title":"Clin Physiol"},{"issue":"4","key":"10.1016\/j.jocd.2021.05.001_bib0034","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2004.03.021","article-title":"Effect of carbamazepine and valproate on bone mineral density","volume":"31","author":"Ecevit","year":"2004","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.jocd.2021.05.001_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocd.2021.05.001_bib0036","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.11.001","article-title":"Activity profile of pregabalin in rodent models of epilepsy and ataxia","volume":"68","author":"Vartanian","year":"2006","journal-title":"Epilepsy Res"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469502100041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469502100041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:44:09Z","timestamp":1761083049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109469502100041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S109469502100041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2021.05.001","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Pregabalin on Bone Metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}